Nine-in-10 consumers who opted for a needle-free flu shot this season would choose that option again and recommend it to family and friends.
ACIP on Thursday recommended that children ages 6 months and older get an annual influenza vaccine with no preference stated for either the nasal spray vaccine or the flu shot.
Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.
The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
A team of researchers at Columbia Engineering has developed a low-cost smartphone accessory that can perform a point-of-care test for HIV or syphilis in just 15 minutes.
A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."
Sharecare on Thursday launched an app that monitors voice inflection as a tool toward better health.
Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo.
Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products.
The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration.